Citations

Clear

26 citation(s) found for "Liu, Chang".

Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis
Okamoto, Kohji , Takada, Tadahiro , Strasberg, Steven M. , Asbun, Horacio J. , Endo, Itaru , Iwashita, Yukio , Hibi, Taizo , Pitt, Henry A. , Umezawa, Akiko , Asai, Koji , Hwang, Tsann‐Long , Mori, Yasuhisa , Huang, Wayne Shih‐Wei, Belli, Giulio, Dervenis, Christos, Yokoe, Masamichi, Kiriyama, Seiki , Itoi, Takao , Jagannath, P., Garden, O. James , Miura, Fumihiko, Wakabayashi, Go , Cherqui, Daniel , Santibáñes, Eduardo de , Shikata, Satoru , Noguchi, Yoshinori , Higuchi, Ryota , Wada, Keita, Supe, Avinash , Yoshida, Masahiro , Mayumi, Toshihiko , Gouma, Dirk J., Deziel, Daniel J., Liau, Kui‐Hin, Chen, Miin‐Fu , Shibao, Kazunori , Liu, Keng‐Hao, Su, Cheng‐Hsi, Chan, Angus C. W., Choi, In‐Seok , Jonas, Eduard , Fan, Sheung Tat , Ker, Chen‐Guo , Giménez, Mariano , Kitano, Seigo, Inomata, Masafumi , Inui, Kazuo, Sumiyama, Yoshinobu, Yamamoto, Masakazu , Suzuki, Kenji S. , Han, Ho-Seong , Yoon, Yoo-Seok , Nakamura, Masafumi , Horiguchi, Akihiko , Ukai, Tomohiko , Honda, Goro , Yoon, Dong Sup , Chen, Xiaoping , Hirata, Koichi , Jonas, Eduard

Mayo Clinic

Journal of Hepato-Biliary-Pancreatic Sciences | October 16, 2017 | Volume: 25 | Issue: 1 | Pages: 55-72

10.1002/jhbp.516 | PMID 29045062 Get It

Abstract We propose a new flowchart for the treatment of acute cholecystitis ( AC ) in the Tokyo Guidelines 2018 (TG18). Grade III AC was not indicated for straightforward laparoscopic cholecystectomy (Lap‐C). Following analysis of subsequent clinical investigations and drawing on Big Data in particular, TG 18 proposes that some Grade III AC can be treated by Lap‐C when performed at advanced centers with specialized surgeons experienced in this procedure and for patients that satisfy certain strict criteria. For Grade I, TG 18 recommends early Lap‐C if the patients meet the criteria of Charlson comorbidity index ( CCI ) ≤5 and American Society of Anesthesiologists physical status classification ( ASA ‐ PS ) ≤2. For Grade II AC , if patients meet the criteria of CCI ≤5 and ASA ‐ PS ≤2, TG 18 recommends early Lap‐C performed by experienced surgeons; and if not, after medical treatment and/or gallbladder drainage, Lap‐C would be indicated. TG 18 proposes that Lap‐C is indicated in Grade III patients with strict criteria. These are that the patients have favorable organ system failure, and negative predictive factors, who meet the criteria of CCI ≤3 and ASA ‐ PS ≤2 and who are being treated at an advanced center (where experienced surgeons practice). If the patient is not considered suitable for early surgery, TG 18 recommends early/urgent biliary drainage followed by delayed Lap‐C once the patient's overall condition has improved. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47 . Related clinical questions and references are also included.
Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis
Miura, Fumihiko, Okamoto, Kohji , Takada, Tadahiro , Strasberg, Steven M. , Asbun, Horacio J. , Pitt, Henry A. , Gomi, Harumi , Solomkin, Joseph S. , Schlossberg, David, Kim, Myung‐Hwan , Hwang, Tsann‐Long , Chen, Miin‐Fu , Huang, Wayne Shih‐Wei, Kiriyama, Seiki , Itoi, Takao , Garden, O. James , Liau, Kui‐Hin, Liu, Keng‐Hao, Su, Cheng‐Hsi, Gouma, Dirk J., Belli, Giulio, Dervenis, Christos, Jagannath, P., Chan, Angus C. W., Lau, Wan Yee , Endo, Itaru , Santibáñes, Eduardo de , Giménez, Mariano , Jonas, Eduard , Singh, Harjit , Asai, Koji , Mori, Yasuhisa , Wada, Keita, Higuchi, Ryota , Rikiyama, Toshiki, Kano, Nobuyasu, Umezawa, Akiko , Tokumura, Hiromi, Hata, Jiro , Kozaka, Kazuto , Iwashita, Yukio , Hibi, Taizo , Yokoe, Masamichi, Kimura, Taizo, Kitano, Seigo, Inomata, Masafumi , Sumiyama, Yoshinobu, Inui, Kazuo, Yamamoto, Masakazu , Han, Ho-Seong , Horiguchi, Akihiko , Suzuki, Kenji S. , Yoon, Yoo-Seok , Honda, Goro , Watanabe, Manabu , Sata, Naohiro , Mukai, Shuntaro , Hirata, Koichi , Jonas, Eduard

Mayo Clinic

Journal of Hepato-Biliary-Pancreatic Sciences | September 23, 2017 | Volume: 25 | Issue: 1 | Pages: 31-40

10.1002/jhbp.509 | PMID 28941329 Get It

AbstractThe initial management of patients with suspected acute biliary infection starts with the measurement of vital signs to assess whether or not the situation is urgent. If the case is judged to be urgent, initial medical treatment should be started immediately including respiratory/circulatory management if required, without waiting for a definitive diagnosis. The patient's medical history is then taken; an abdominal examination is performed; blood tests, urinalysis, and diagnostic imaging are carried out; and a diagnosis is made using the diagnostic criteria for cholangitis/cholecystitis. Once the diagnosis has been confirmed, initial medical treatment should be started immediately, severity should be assessed according to the severity grading criteria for acute cholangitis/cholecystitis, and the patient's general status should be evaluated. For mild acute cholangitis, in most cases initial treatment including antibiotics is sufficient, and most patients do not require biliary drainage. However, biliary drainage should be considered if a patient does not respond to initial treatment. For moderate acute cholangitis, early endoscopic or percutaneous transhepatic biliary drainage is indicated. If the underlying etiology requires treatment, this should be provided after the patient's general condition has improved; endoscopic sphincterotomy and subsequent choledocholithotomy may be performed together with biliary drainage. For severe acute cholangitis, appropriate respiratory/circulatory management is required. Biliary drainage should be performed as soon as possible after the patient's general condition has been improved by initial treatment and respiratory/circulatory management. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47. Related clinical questions and references are also included.
Tokyo Guidelines 2018: management strategies for gallbladder drainage in patients with acute cholecystitis (with videos)
Mori, Yasuhisa , Itoi, Takao , Baron, Todd H. , Takada, Tadahiro , Strasberg, Steven M. , Pitt, Henry A. , Ukai, Tomohiko , Shikata, Satoru , Noguchi, Yoshinori , Kim, Myung‐Hwan , Asbun, Horacio J. , Endo, Itaru , Yokoe, Masamichi, Miura, Fumihiko, Okamoto, Kohji , Umezawa, Akiko , Iwashita, Yukio , Hibi, Taizo , Wakabayashi, Go , Choi, In‐Seok , Hwang, Tsann‐Long , Chen, Miin‐Fu , Garden, O. James , Singh, Harjit , Liau, Kui‐Hin, Huang, Wayne Shih‐Wei, Gouma, Dirk J., Belli, Giulio, Dervenis, Christos, Santibáñes, Eduardo de , Giménez, Mariano , Windsor, John A. , Lau, Wan Yee , Cherqui, Daniel , Jagannath, P., Supe, Avinash , Liu, Keng‐Hao, Su, Cheng‐Hsi, Deziel, Daniel J., Fan, Sheung Tat , Ker, Chen‐Guo , Jonas, Eduard , Padbury, Robert , Sugioka, Atsushi , Asai, Koji , Higuchi, Ryota , Wada, Keita, Yoshida, Masahiro , Mayumi, Toshihiko , Sumiyama, Yoshinobu, Inui, Kazuo, Yamamoto, Masakazu , Teoh, Anthony Yuen Bun , Suzuki, Kenji S. , Han, Ho-Seong , Yoon, Yoo-Seok , Chen, Xiao‐Ping , Mukai, Shuntaro , Honda, Goro , Hirata, Koichi , Jonas, Eduard

Mayo Clinic

Journal of Hepato-Biliary-Pancreatic Sciences | September 9, 2017 | Volume: 25 | Issue: 1 | Pages: 87-95

10.1002/jhbp.504 | PMID 28888080 Get It

Abstract Since the publication of the Tokyo Guidelines in 2007 and their revision in 2013, appropriate management for acute cholecystitis has been more clearly established. Since the last revision, several manuscripts, especially for alternative endoscopic techniques, have been reported; therefore, additional evaluation and refinement of the 2013 Guidelines is required. We describe a standard drainage method for surgically high‐risk patients with acute cholecystitis and the latest developed endoscopic gallbladder drainage techniques described in the updated Tokyo Guidelines 2018 ( TG 18). Our study confirmed that percutaneous transhepatic gallbladder drainage should be considered the first alternative to surgical intervention in surgically high‐risk patients with acute cholecystitis. Also, endoscopic transpapillary gallbladder drainage or endoscopic ultrasound‐guided gallbladder drainage can be considered in high‐volume institutes by skilled endoscopists. In the endoscopic transpapillary approach, either endoscopic naso‐gallbladder drainage or gallbladder stenting can be considered for gallbladder drainage. We also introduce special techniques and the latest outcomes of endoscopic ultrasound‐guided gallbladder drainage studies. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47 . Related clinical questions and references are also included.
Using whole‐exome sequencing to investigate the genetic bases of lysosomal storage diseases of unknown etiology
Wang, Nan , Zhang, Yeting , Gedvilaite, Erika , Loh, Jui Wan , Lin, Timothy, Liu, Xiuping , Liu, Chang‐Gong, Kumar, Dibyendu , Donnelly, Robert, Raymond, Kimiyo , Schuchman, Edward H. , Sleat, David E. , Lobel, Peter , Xing, Jinchuan

Mayo Clinic

Human Mutation | July 13, 2017 | Volume: 38 | Issue: 11 | Pages: 1491-1499

10.1002/humu.23291 | PMID 28703315 Get It

Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells
Ghosh, Asish K. , Shanafelt, Tait D. , Cimmino, Amelia , Taccioli, Cristian , Volinia, Stefano , Liu, Chang‐Gong, Calin, George A. , Chan, Denise A., Secreto, Charla, Wellik, Linda, Croce, Carlo Maria , Giaccia, Amato J. , Lee, Yean Kee , Mukhopadhyay, Debabrata , Kay, Neil E. , Shanafelt, Tait D

Mayo Clinic

Blood | March 31, 2009 | Volume: 113 | Issue: 22 | Pages: 5568-5574

10.1182/blood-2008-10-185686 | PMID 19336759 Get It

The molecular mechanism of autocrine regulation of vascular endothelial growth factor (VEGF) in chronic lymphocytic leukemia (CLL) B cells is unknown. Here, we report that CLL B cells express constitutive levels of HIF-1α under normoxia. We have examined the status of the von Hippel-Lindau gene product (pVHL) that is responsible for HIF-1α degradation and found it to be at a notably low level in CLL B cells compared with normal B cells. We demonstrate that the microRNA, miR-92-1, overexpressed in CLL B cells, can target the VHL transcript to repress its expression. We found that the stabilized HIF-1α can form an active complex with the transcriptional coactivator p300 and phosphorylated-STAT3 at the VEGF promoter and recruit RNA polymerase II. This is initial evidence that pVHL, without any genetic alteration, can be regulated by microRNA and explains the aberrant autocrine VEGF secretion in CLL.
Imaging of Focal Hepatic Lesions:Self-Assessment Module
Liu, Chang-Hsien, Rivard, Douglas C., Silva, Alvin C. , Burkholz, Kimberly J., Beaty, Sean D.

Mayo Clinic

American Journal of Roentgenology | May 20, 2008 | Volume: 190 | Issue: 6_supplement | Pages: S65-S68

10.2214/ajr.07.7076 | PMID 18492934 Get It